August 5, 2025 - 23:09

Linda Yaccarino has officially stepped into the role of CEO at eMed, a health company dedicated to providing care for users of GLP-1 medications. This significant career move comes on the heels of her departure from Elon Musk's X in July. Yaccarino, known for her extensive experience in media and advertising, is poised to bring her expertise to the healthcare sector, particularly in the growing field of GLP-1 treatments, which are increasingly popular for weight management and diabetes care.
At eMed, Yaccarino will be tasked with navigating the complexities of the health industry while driving innovation and expanding the company's reach. Her appointment signals a strategic shift for eMed, aiming to enhance patient care and accessibility in a rapidly evolving market. As she embarks on this new chapter, industry watchers are eager to see how her leadership will influence the company's trajectory and its impact on healthcare solutions for GLP-1 users.
July 9, 2026 - 18:31
Bat exposure warning linked to Mount Airy fireworks showHealth officials in Carroll County are advising anyone who attended the Mount Airy Fourth of July fireworks display to watch for potential bat exposure. The Carroll County Health Department...
July 9, 2026 - 15:45
James Bond and Marvel body double opens up about mental healthJason Burrill, a professional body double from Seaford, has worked behind the scenes on some of the biggest blockbuster franchises in Hollywood, including James Bond and the Marvel Cinematic...
July 8, 2026 - 18:48
What's in Store for the NACCHO360 2026 EventPlanning for the NACCHO360 2026 event is already underway, and attendees can look forward to a packed schedule of sessions and networking opportunities. This year, several key presentations will...
July 8, 2026 - 10:31
Academic Excellence Award WinnerErin, an Academic Excellence Award winner and a Public and Community Health major with double minors in Legal Studies and Health Policy and Management, recently shared her experiences at Ithaca...